08Oct/13

CELLMID LIMITED : Key European Patent for Anti-Midkine Antibodies Granted – 4-traders (press release)


Proactive Investors Australia

CELLMID LIMITED : Key European Patent for Anti-Midkine Antibodies Granted
4-traders (press release)
The granted claims cover Cellmid’s cancer program for antibodies and antibody fragments which bind to the important functional C-domain of growth factor midkine (MK). In particular, antibodies of any kind that bind to key MK C-domain epitopes are covered.
Cellmid awarded key European midkine antibodies patent, covers cancer and Proactive Investors Australia
Cellmid, Key European Patent for Anti-Midkine Antibodies GrantedFinance News Network

all 3 news articles »

07Oct/13

Donation of prominent Muslim's body to science sparks debate – Khabar South Asia


Khabar South Asia

Donation of prominent Muslim’s body to science sparks debate
Khabar South Asia
The donation of the body of a prominent Indian Muslim to a medical college has triggered a controversy in India, with many Muslim clerics claiming the act is un-Islamic. But one top Islamic scholar says neither the Qur’an nor the Hadith forbid organ